2026 Pilot Translational Award
The 2026 Pilot Translational Award from the Melanoma Research Foundation funds innovative one-year translational or clinical melanoma research to lay groundwork for future multicenter studies.
Funder: Melanoma Research Foundation
Due Dates: August 17, 2026 (Application Submission Deadline, 11:59 PM ET)
Funding Amounts: $50,000 total for a one-year project; direct costs only; no indirect costs allowed.
Summary: Supports innovative, one-year translational or clinical melanoma research projects with potential for future multicenter studies.
Description
This funding opportunity from the Melanoma Research Foundation Breakthrough Consortium (MRFBC) is designed to accelerate the development of promising therapies for melanoma by supporting innovative, one-year pilot projects in clinical or translational research. The award specifically seeks to fund projects that generate findings foundational for larger, multicenter efforts, with an emphasis on scientific rigor, innovation, and potential impact on melanoma treatment. While the award does not support clinical trials directly, it can fund correlative or bioinformatic research linked to clinical trials, as well as studies utilizing human specimens or patient-derived materials.
